H. Ohno
Research Subjects
Research Interests
H. Ohno has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
Masafumi Higashidate
Department of Cardiovascular Surgery, National Yokohama Hospital, 3-60-2 Harajuku, Totsuka-ku, Yokohama 245-8575, Japan
1 shared publicationTatsuya Yokosuka
Department of Cardiovascular Surgery, National Yokohama Hospital, 3-60-2 Harajuku, Totsuka-ku, Yokohama 245-8575, Japan
1 shared publication
Latest Publications
- 1 February 2003
- Published by Springer Nature in Heart and Vessels
- Vol. 18 (1) , 40-42
Argatroban as an alternative anticoagulant for patients with heparin allergy during coronary bypass surgery
Although heparin allergy is a rare but well-documented entity, anticoagulation management for cardiac surgery in patients with the heparin allergy has not been established due to its rarity. Here we report a case that shows our anticoagulation strategy during a coronary bypass operation. A 67-year-old man with unstable angina pectoris developed an urticarial rash 10 h after the second exposure to heparin. Results of the drug lymphocyte stimulation test were positive for porcine heparin, coumadin, and nicorandil. Off-pump coronary bypass surgery was successfully performed with argatroban as an alternative anticoagulant to heparin, with activated clotting time kept over 200 s at the rate of 5 μg/kg per min of argatroban infusion.
- 1 February 2003
- Published by Springer Nature in Heart and Vessels
- Vol. 18 (1) , 40-42
Argatroban as an alternative anticoagulant for patients with heparin allergy during coronary bypass surgery
Although heparin allergy is a rare but well-documented entity, anticoagulation management for cardiac surgery in patients with the heparin allergy has not been established due to its rarity. Here we report a case that shows our anticoagulation strategy during a coronary bypass operation. A 67-year-old man with unstable angina pectoris developed an urticarial rash 10 h after the second exposure to heparin. Results of the drug lymphocyte stimulation test were positive for porcine heparin, coumadin, and nicorandil. Off-pump coronary bypass surgery was successfully performed with argatroban as an alternative anticoagulant to heparin, with activated clotting time kept over 200 s at the rate of 5 μg/kg per min of argatroban infusion.